<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03434795</url>
  </required_header>
  <id_info>
    <org_study_id>2011_40</org_study_id>
    <secondary_id>912180</secondary_id>
    <secondary_id>12-272</secondary_id>
    <nct_id>NCT03434795</nct_id>
  </id_info>
  <brief_title>Distinction Risk of Severe Infection in Febrile Neutropenia After Chemotherapy</brief_title>
  <official_title>Distinction Risk of Severe Infection in Febrile Neutropenia After Chemotherapy: a Multicenter Validation of Clinical Decision Rule</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Lille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Health, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ligue contre le cancer, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Lille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluate the reproducibility and validate a posteriori a new rule of clinical decision on a
      multi-center population of children with a post-chemotherapy febrile neutropenia
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2012</start_date>
  <completion_date type="Actual">May 2017</completion_date>
  <primary_completion_date type="Actual">May 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Blood culture</measure>
    <time_frame>On average between 5 days and 1 month</time_frame>
    <description>Presence or not of bacteriemia</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Positive bacterial culture from a normally sterile site</measure>
    <time_frame>on average between 5 days and 1 month</time_frame>
    <description>Presence or not of bacterial infection</description>
  </primary_outcome>
  <primary_outcome>
    <measure>microbiological culture</measure>
    <time_frame>On average between 5 days and 1 month</time_frame>
    <description>Presence or not of focal infection at high risk of dissemination was defined as any local infection with or without microbiological documentation into a normally sterile site, with significant risk of loco-regional or systemic spread</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Fungal culture</measure>
    <time_frame>On average between 5 days and 1 month</time_frame>
    <description>Presence or not of fungal infection is referred to a proven, probable, or possible fungal infection as defined by the IFICG ot the EORTC</description>
  </primary_outcome>
  <enrollment type="Actual">1900</enrollment>
  <condition>Febrile Neutropenia, Rule of Clinical Decision, Chemotherapy</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patient with hematology or cancer who consults for febrile neutropenia post-chemotherapy
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Child aged 1 to 18 years

          -  Child with hematology or cancer

          -  Child with a febrile neutropenia post-chemotherapy

          -  Child with social security

          -  No opposition from the child and/or parents, in case of absence, the holder of the
             parental authority present, can consent, alone, to the participation of the
             unemancipated minor.

        Exclusion Criteria:

          -  Febrile neutropenia at diagnosis of tumor disease

          -  Child with palliative care

          -  Child having had a hematopoietic stem cell allo-graft in the preceding year

          -  Febrile neutropenia immediately post auto-transplant

          -  Antibiotherapy prior to admission

          -  Initial care in a non-investigative center.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>François Dubos, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Lille</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hôpital Jeanne de Flandre - CHRU de Lille</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 18, 2018</study_first_submitted>
  <study_first_submitted_qc>February 13, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 15, 2018</study_first_posted>
  <last_update_submitted>February 13, 2018</last_update_submitted>
  <last_update_submitted_qc>February 13, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neutropenia</mesh_term>
    <mesh_term>Fever</mesh_term>
    <mesh_term>Febrile Neutropenia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

